Evidence map›Paper›PMID 38512516›Full record

ArticleAbdominal radiology (New York)2024

Automated prostate gland segmentation in challenging clinical cases: comparison of three artificial intelligence methods.

Latrice A Johnson, Stephanie A Harmon, Enis C Yilmaz, Yue Lin, Mason J Belue, Katie M Merriman, Nathan S Lay, Thomas H Sanford, Karthik V Sarma, Corey W Arnold and 12 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Integrating Artificial Intelligence into Prostate MR Imaging: Technical Foundations, Clinical Applications, and Workflow Implications.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Review
  2. Article
  3. AI in Prostate MRI: A Task-Based Review.Journal of the Korean Society of Radiology · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 6 institutions in 1 country.

Latrice A JohnsonMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Stephanie A HarmonMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Enis C YilmazMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Yue LinMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Mason J BelueMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Katie M MerrimanMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Nathan S LayMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Thomas H SanfordDepartment of Urology, Hawaii Pacific Health, Honolulu, HI, USA.
Karthik V SarmaDepartment of Psychiatry and Behavioral Sciences, University of California, San Francisco, CA, USA.
Corey W ArnoldDepartment of Radiology, University of California, Los Angeles, Los Angeles, CA, USA.
Ziyue XuNVIDIA Corporation, Santa Clara, CA, USA.
Holger R RothNVIDIA Corporation, Santa Clara, CA, USA.
Dong YangNVIDIA Corporation, Santa Clara, CA, USA.
Jesse TetreaultNVIDIA Corporation, Santa Clara, CA, USA.
Daguang XuNVIDIA Corporation, Santa Clara, CA, USA.
Krishnan R PatelRadiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Sandeep GurramUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Bradford J WoodCenter for Interventional Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.
Deborah E CitrinRadiation Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Peter A PintoUrologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Peter L ChoykeMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Baris TurkbeyMolecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. turkbeyi@mail.nih.gov.ORCID http://orcid.org/0000-0003-0853-6494
National Institutes of Health · USNvidia (United States) · USNational Cancer Institute · USPacific Health Research and Education Institute · USUniversity of California, Los Angeles · USUniversity of California, San Francisco · US

Funding

Prostate Cancer ImagingZIABC010655 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CHOYKE, PETER L · 2009 to 2025
$49.2M
Center for Interventional OncologyZIDBC011242 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2009 to 2025
$18.7M
Targeting mechanisms of radiation resistanceZIABC011552 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CITRIN, DEBORAH · 2014 to 2025
$12.2M
Imaging, image guided biopsy and treatment of prostate cancerZIABC012062 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TÜRKBEY, BARIS · 2021 to 2025
$1.3M
Development of COVID-19 Imaging Tools with Artificial IntelligenceZIABC011936 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WOOD, BRADFORD J · 2020 to 2025
$1.2M
Interventional OncologyZIACL040015 · CLC · CLINICAL CENTER · PI WOOD, BRADFORD · 2009 to 2025
$0k
6 · The paper itself

Abstract

objectiveAutomated methods for prostate segmentation on MRI are typically developed under ideal scanning and anatomical conditions. This study evaluates three different prostate segmentation AI algorithms in a challenging population of patients with prior treatments, variable anatomic characteristics, complex clinical history, or atypical MRI acquisition parameters. MATERIALS AND

methodsA single institution retrospective database was queried for the following conditions at prostate MRI: prior prostate-specific oncologic treatment, transurethral resection of the prostate (TURP), abdominal perineal resection (APR), hip prosthesis (HP), diversity of prostate volumes (large ≥ 150 cc, small ≤ 25 cc), whole gland tumor burden, magnet strength, noted poor quality, and various scanners (outside/vendors). Final inclusion criteria required availability of axial T2-weighted (T2W) sequence and corresponding prostate organ segmentation from an expert radiologist. Three previously developed algorithms were evaluated: (1) deep learning (DL)-based model, (2) commercially available shape-based model, and (3) federated DL-based model. Dice Similarity Coefficient (DSC) was calculated compared to expert. DSC by model and scan factors were evaluated with Wilcox signed-rank test and linear mixed effects (LMER) model.

results683 scans (651 patients) met inclusion criteria (mean prostate volume 60.1 cc [9.05-329 cc]). Overall DSC scores for models 1, 2, and 3 were 0.916 (0.707-0.971), 0.873 (0-0.997), and 0.894 (0.025-0.961), respectively, with DL-based models demonstrating significantly higher performance (p < 0.01). In sub-group analysis by factors, Model 1 outperformed Model 2 (all p < 0.05) and Model 3 (all p < 0.001). Performance of all models was negatively impacted by prostate volume and poor signal quality (p < 0.01). Shape-based factors influenced DL models (p < 0.001) while signal factors influenced all (p < 0.001).

conclusionFactors affecting anatomical and signal conditions of the prostate gland can adversely impact both DL and non-deep learning-based segmentation models.

Indexed as

AlgorithmsArtificial IntelligenceMagnetic Resonance ImagingProstatic NeoplasmsAgedDeep LearningHumansImage Interpretation, Computer-AssistedMaleMiddle AgedProstateRetrospective StudiesDeep learningMachine learningMagnetic resonance imagingProstateSegmentation

Identifiers

PMID38512516
OpenAlexW4393039938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.